Hexokinase 2 Inhibitor Screening With Graphite MALDI-MS
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Conventional matrix-assisted laser desorption ionization mass spectrometry (MALDI-MS) techniques face challenges in analyzing small molecules due to high background noise and low sensitivity, especially in the low mass-to-charge ratio region, which hinders the development of effective antitumor drug screening and imaging.
Innovation Solution
A method using a graphite structure type nanomaterial matrix combined with MALDI-MS for screening hexokinase 2 inhibitors, involving mixing a candidate inhibitor with a buffer solution containing hexokinase 2 and glucose, followed by incubation and analysis using MALDI-MS, allowing for rapid and accurate identification of hexokinase 2 inhibitors with high brain tumor growth activity inhibitory properties.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If conventional organic matrix is used in MALDI-MS, then the method can rapidly analyze biomacromolecules, but it generates very high background noise in low mass-to-charge ratio region which disturbs small molecule analysis
Solution Approach 1:
The patent changes the fundamental parameter of the matrix material from organic to inorganic nanomaterials (such as silicon, metal oxides, carbon nanomaterials). This parameter change eliminates the background noise issue in low mass-to-charge ratio region while preserving the rapid analysis capability of MALDI-MS for small molecules.
2Object-affected harmful factors
If inorganic nanomaterials are used as matrices to overcome background interference, then low molecular weight region analysis is improved, but sensitivity and repeatability for in vivo small molecule testing deteriorate
Solution Approach 1:
The patent applies local quality by creating a hierarchical structure where inorganic nanomaterials serve as the matrix substrate, and organic matrix materials are deposited on their surfaces. This local combination allows the inorganic core to provide low background noise while the organic surface layer restores sensitivity and repeatability for in vivo small molecule testing.
Solution Approach 2:
The patent creates a composite material system combining inorganic nanomaterials with organic matrix materials. The inorganic component (silicon, metal oxides, or carbon nanomaterials) provides low background interference, while the organic component restores the sensitivity and repeatability needed for detecting small molecules in biological samples.
3Speed
If computer screening is used to obtain target molecules, then the process speed is fast, but actual experimental conditions such as reagents are lacked
Solution Approach 1:
The patent performs preliminary computer screening to identify candidate molecules, then validates them using the developed MALDI-MS method with inorganic nanomaterial matrices. This preliminary action allows rapid identification of potential candidates followed by reliable experimental verification under actual physiological conditions, combining speed with completeness.
4Speed
If conventional LC-MS systems with ultra-fast gradient short columns are used, then analysis speed is improved, but only limited number of blood samples can be analyzed within specific time
Solution Approach 1:
The patent extracts the matrix material function from the conventional LC-MS system and implements it as a standalone inorganic nanomaterial-based MALDI platform. This extraction allows direct analysis of multiple blood samples without chromatographic separation, achieving both high analysis speed and high sample throughput (enabling analysis of many more than 768 samples in 3.75 hours).
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables ultra-rapid and highly accurate screening of hexokinase 2 inhibitors, allowing for the analysis of 1836 samples within 5.1 hours, breaking through limitations of traditional methods and enabling the identification of small-molecule compounds with potent antitumor activity that can penetrate the blood-brain barrier.
Implementation Method 1
matrix-assisted laser desorption ionization mass spectrometry (MALDI-MS) testing
Implementation Method 2
matrix-assisted laser desorption ionization mass spectrometry (MALDI-MS) testing
Data Source
AI summary
The present invention provides an application of a small-molecule compound in preparation of an antitumor drug. A series of small-molecule drugs with high brain tumor growth activity inhibitory properties are obtained, are docked to pharmacodynamic analysis of the small-molecule drugs, and do not need to be transferred to other testing platforms.